No Data
No Data
Results of GRAIL's Galleri Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology
Here's How Much $1000 Invested In Illumina 20 Years Ago Would Be Worth Today
Illumina Price Target Announced at $150.00/Share by Argus Research
Argus Research Upgrades Illumina(ILMN.US) to Buy Rating, Announces Target Price $150
Illumina's TruSight Oncology Biomarker Test Gets FDA Approval
Express News | Illumina: Tso Comprehensive Will Begin Shipping to Customers This Year
102680687 : why sudden drop